Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME Dermatan sulfate hydrolytic enzyme DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Mucopolysaccharidosis VI 3 D009087 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Respiratory, thoracic and mediastinal disorders
19.33
General disorders and administration site conditions
12.89
Infections and infestations
10.86
Nervous system disorders
10.83
Cardiac disorders
6.3
Gastrointestinal disorders
6.29
Musculoskeletal and connective tissue disorders
5.31
Injury, poisoning and procedural complications
4.08
Skin and subcutaneous tissue disorders
3.81
Vascular disorders
3.48
Surgical and medical procedures
2.49
Investigations
2.25

Cross References

Resources Reference
CAS NUMBER 552858-79-4
ChEMBL CHEMBL1201822
FDA SRS 59UA429E5G